← Back to Search

Virtual implementation protocol for Mood Disorders

N/A
Waitlist Available
Led By Nancy Byatt, DO, MS, MBA, FACLP
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
licensed independent providers e.g. Ob/Gyn attendings and residents, family medicine, Maternal Fetal Medicine physicians (attending/fellow), certified nurse midwives, nurse practitioners, and physician assistants)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 month and 13 months
Awards & highlights

Study Summary

This trial will test whether an e-learning course can help obstetric providers address perinatal mood and anxiety disorders, as compared to no course or usual care.

Eligible Conditions
  • Mood Disorders
  • Anxiety Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 month and 13 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 month and 13 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Bipolar Disorder
Secondary outcome measures
Change in Providers' quality of care for perinatal mood and anxiety disorders
Change in rates of screening for anxiety disorder during the 1st or 2nd half of pregnancy
Other outcome measures
Change in Provider Self-Reported rate of Screening
Change in Provider Subject Matter Knowledge acquisition and retention
Change in Provider attitudes and beliefs related to perinatal mood and anxiety disorders
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Virtual implementation protocolExperimental Treatment2 Interventions
Participants assigned to the virtual implementation protocol plus e-learning/toolkit group will take the e-learning course an also receive support through the Virtual Implementation Protocol.
Group II: E-learning/toolkit aloneActive Control1 Intervention
Participants assigned to the e-learning/toolkit alone group will only complete the e-learning course/receive the e-learning toolkit.
Group III: Treatment as usualActive Control1 Intervention
Participants assigned to this group will not be provided any additional training or implementation assistance. They will be able to take trainings outside of study protocol if they would otherwise plan or want to do so. They will be offered the study-specific training and implementation assistance after they have completed the final study assessments.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual implementation protocol
2021
N/A
~140
e-learning toolkit
2021
N/A
~140

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
341 Previous Clinical Trials
973,330 Total Patients Enrolled
2 Trials studying Mood Disorders
50 Patients Enrolled for Mood Disorders
Praxis, Inc.UNKNOWN
National Institute of Mental Health (NIMH)NIH
2,775 Previous Clinical Trials
2,673,645 Total Patients Enrolled
73 Trials studying Mood Disorders
45,403 Patients Enrolled for Mood Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots left open for participants in this investigation?

"Unfortunately, clinicaltrials.gov reports that this medical study is no longer recruiting patients as the trial was last updated on November 3rd 2022 and it was first posted August 17th 2021. However, there are plenty of other trials seeking participants with more than 2211 studies open right now."

Answered by AI
Recent research and studies
~39 spots leftby Mar 2025